nonvalvular atrial fibrillation
is a novel oral anticoagulant approved for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism.
is a novel oral anticoagulant approved for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation ( NVAF ) and the treatment of venous thromboembolism .